TCBWMS
ACTU

Texas Capital Bank Wealth Management Services’s Actuate Therapeutics ACTU Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
102,612
+8,020
+8% +$18.6K 0.01% 344
2026
Q1 		$259K Hold
94,592
– – 0.02% 302
2025
Q4 		$579K Buy
+94,592
New +$650K 0.03% 184

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $159M AUM 34.17% 1-Year Est. Return
AIM
ABS Investment Management Greenwich, Connecticut $159M AUM

Texas Capital Bank Wealth Management Services's ACTU Position: Q2 2026 in Review

Texas Capital Bank Wealth Management Services increased its Actuate Therapeutics (ACTU) stake by 8.5% in Q2 2026, buying an estimated $18.6K and bringing the position to 102,612 shares worth $157K. The position accounts for 0.01% of the portfolio, ranked #344.

Texas Capital Bank Wealth Management Services first reported a position in ACTU in Q4 2025 and has held it in 3 quarters since. The position peaked at $579K in Q4 2025. 63 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • Texas Capital Bank Wealth Management Services held 102,612 shares of Actuate Therapeutics worth $157K as of Q2 2026.
  • Texas Capital Bank Wealth Management Services bought 8,020 Actuate Therapeutics shares in Q2 2026, an estimated $18.6K.
  • Actuate Therapeutics made up 0.01% of Texas Capital Bank Wealth Management Services's portfolio in Q2 2026, its #344 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Actuate Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Texas Capital Bank Wealth Management Services's Actuate Therapeutics position peaked at $579K in Q4 2025.
  • 63 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q2 2026, filed 7 Aug 2026.